Skip to Content
Merck
CN

P0169

Sigma-Aldrich

Palmityl palmitate

≥99%

Synonym(s):

Cetyl palmitate, Hexadecyl hexadecanoate, Palmitic acid palmityl ester

Sign Into View Organizational & Contract Pricing

About This Item

Linear Formula:
CH3(CH2)14CO2(CH2)15CH3
CAS Number:
540-10-3
Molecular Weight:
480.85
EC Number:
208-736-6
MDL number:
MFCD00053739
UNSPSC Code:
12352211
PubChem Substance ID:
24898081
NACRES:
NA.25

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

synthetic (organic)

Quality Level

200

Assay

≥99%

form

powder

mp

55-56 °C (lit.)

functional group

ester

lipid type

saturated FAs

shipped in

ambient

storage temp.

2-8°C

SMILES string

CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC

InChI

1S/C32H64O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-34-32(33)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-31H2,1-2H3

InChI key

PXDJXZJSCPSGGI-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Storage Class Code

11 - Combustible Solids

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000426998
0000426997
0000426997
0000426998
0000392379

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Paolo Blasi et al.
International journal of pharmaceutics, 419(1-2), 287-295 (2011-08-11)
The aim of this study was to optimize the formulation of lipid nanoparticles (NPs), intended for brain targeting, with the aid of a computer generated experimental design. The high pressure homogenization technique, selected for this purpose, was suitable to formulate
G Lukowski et al.
International journal of pharmaceutics, 196(2), 201-205 (2000-03-04)
Solid lipid nanoparticles (SLN) as alternative intravenous colloidal drug carriers were produced by high pressure homogenisation of the melted lipid cetylpalmitate. The crystallographic properties of the used cetylpalmitate SLN were characterised by small angle X-ray scattering (SAXS) and X-ray diffraction
C Carbone et al.
European journal of medicinal chemistry, 49, 110-117 (2012-01-17)
The objective of this study was the preparation, physico-chemical characterization and statistical optimization of cationic solid lipid nanoparticles (SLN) prepared by the PIT method as potential carrier for gene therapy, emphasizing the application of factorial design in such a kind
A Lippacher et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 53(2), 155-160 (2002-03-07)
Aqueous solid lipid nanoparticle (SLN) dispersions with a high lipid content up to 35% and viscous to semisolid consistency were produced by a high pressure homogenization process. Despite their high lipid content and viscosity these dispersions preserved their colloidal size
S Martins et al.
International journal of pharmaceutics, 430(1-2), 216-227 (2012-04-03)
The aim of this work was to develop a systematic analysis of the cellular internalisation mechanism and pathway of solid lipid nanoparticles (SLN) internalisation. To evaluate if SLN show cell uptake and to understand the mechanism of internalisation, four human
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service